News

Recently unveiled technology that aims at early detection and tracking of AMD can prevent vision loss and improve quality of life in patients with the disease.

In a randomly assigned study, including 487 eyes with a leaking clear corneal incision after cataract surgery, closure with a hydrogel sealant was significantly more effective than suturing for preventing fluid egress and was associated with significantly fewer adverse events.

The CRS’s assortment of technology used in cataract surgery allows interaction between devices to give better results before and after a procedure.

With femtosecond laser lens pretreatment and optimization of the surgical approach, removal of even dense cataracts (LOCS III grade 4) can now be completed without any ultrasound in nearly all cases.

: The Verion Image Guided System (Alcon Laboratories), composed of the Verion Reference Unit and the Verion Digital Marker, allows cataract surgeons to deliver better refractive outcomes.

Femtophaco surgical procedures using a femtosecond laser have resulted in much-improved cataract and corneal outcomes.

Recently unveiled device features video of intraoperative wavefront data that allows cataract surgeons to see continuous real-time refraction changes during surgery.

Study suggests that new IOL measurement technology works more effectively than previously thought, however, still rely upon aspects of existing formulae to determine the final lens power.

Photodynamic therapy has been found to reduce subretinal fluid and increase visual acuity for patients with central serous chorioretinopathy.

An investigational modular IOL was designed to improve surgeons’ ability to select the right optic the first time, enable safe and easy postoperative enhancement when required, and minimize posterior capsule opacification. A multicenter clinical trial evaluating the IOL was launched in October.

Analysis finds procedure extremely cost effective; ROI has net $123.4 billion over 13 years

Steven J. Fliesler, PhD, has been chosen as an Association for Research in Vision Ophthalmology (ARVO) 2014 Gold Fellow.

Despite recent advances in prevention and treatment of most vision loss attributed to diabetes, a new study has shown that fewer than half of Americans with damage to their eyes from diabetes are aware of the link between the disease and visual impairment, and only 6 in 10 had their eyes fully examined in the year leading up to the study.

The FDA has accepted for standard review Regeneron Pharmaceuticals Inc.’s supplemental Biologics License Application (sBLA) of aflibercept (Eylea) for the treatment of diabetic macular edema (DME).

Sightpath Medical has announced that it will offer Alcon Laboratory’s Centurion Vision System as an option in their cataract surgery suite of equipment and services.

Use of intraoperative aberrometry significantly improves refractive and visual outcomes after toric IOL implantation, according to a retrospective study presented by Kathryn Hatch, MD.

Adalimumab may be a viable treatment option for patients with steroid-resistant refractory pediatric uveitis, according to a study published in the Journal of the American Association for Pediatric Ophthalmology and Strabismus.

OneSight has announced that in 2014, it will expand its sustainable programs and conduct 50 charitable vision clinics in 14 countries.

Associated vision-related disorders, such as computer vision syndrome-which affects about 90% of people who spend 3 or more hours per day looking at a computer screen-are growing due to a rising compulsion for technological devices, according to Sandy T. Feldman, MD.

QLT Inc. has announced that the first patient in the company’s phase IIa proof-of-concept trial of QLT091001 in adult subjects with impaired dark adaption (IDA) has been dosed.

Bioabsorbable punctal plugs show significant clinical potential for intraocular drug delivery, according to clinical data from a proof-of-concept trial of intracanalicular plugs (Ocular Therapeutix).

Alimera Sciences Inc. has entered into labeling discussions with the FDA for its sustained-release intravitreal implant (Iluvien), and as a result, has reached an agreement that the company’s participation in the 2014 Dermatologic and Ophthalmic Advisory Committee is no longer necessary.

The FDA has given verbal notice indicating the agency’s intent to review STAAR Surgical Co.’s premarket approval (PMA) supplement regarding its toric ICL.

Katena has announced its acquisition of IOP Ophthalmics of Costa Mesa, CA.

Exposure for even fractions of a second to high-powered blue handheld laser devices can cause serious eye injuries, according to a study recently published online in Ophthalmology, the journal of the American Academy of Ophthalmology.

The new patient interface (SoftFit) for the LenSx femtosecond laser (Alcon Laboratories) is elegant technology that improves usability and performance of the laser, according to Michael C. Knorz, MD.

Experts discuss the growing market of MIGS, as well as their benefits and possible concerns, while examining alternative non-invasive intervention methods.